Abstract Background In recent years, more studies have observed that patients with PraderWilli syndrome have lower insulin levels and lower insulin resistance than body mass index-matched controls, which may suggest protected glucose metabolism
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
Our team has reviewed this process across hundreds of research protocols
REDEFINE 11: a higher-dose follow-up Novo Nordisk has a higher-dose CagriSema trial (REDEFINE 11) running in parallel, expected to report in the first half of 2027
Sleep apnea improves, arthritis improves, heart failure improves, heart disease improves
To view a copy of this licence, visit About this article Cite this article Jackson, S.E., Brown, J., Llewellyn, C